BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Saturday, June 6, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 22, 2022
View Archived Issues
NiKang Therapeutics patents new PROTACs for cancer
Read More
Genzyme discloses new CSF-1R inhibitors
Read More
Gilead Sciences synthesizes new PADI4 inhibitors
Read More
University of California presents new CYP3A4 inhibitors
Read More
MEKanistic Therapeutics identifies new PI3K and/or EGFR inhibitors
Read More
GATA1 c.616A>C mutation tied to thrombocytopenia due to platelet formation impairment
Read More
Inosine released by apoptotic brown adipocytes regulates thermogenic fat and counteracts obesity
Read More
PAN domain regulates binding and activation of the c-MET pathway and may be an anticancer target
Read More
Novel variants in genes HPS3, HPS5 and DTNBP1 linked to Hermansky-Pudlak syndrome
Read More
Preclinical characterization of novel antileishmanial agents
Read More
PharmaCyte begins pig study to support planned clinical trial of CypCaps for pancreatic cancer
Read More
FDA clears IND for Obsidian's TIL therapy OBX-115
Read More
Sosei and Cancer Research UK agree to advance EP4 antagonist HTL-0039732 into clinic
Read More
Oncogenic collagen allows cancer cells to evade immune response
Read More
